z-logo
Premium
Synthesis of 2,4‐diamino‐5,10‐dideaza nonclassical antifolates
Author(s) -
Gangjee Aleem,
Devraj Rajesh,
Lin FuTyan
Publication year - 1991
Publication title -
journal of heterocyclic chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.321
H-Index - 59
eISSN - 1943-5193
pISSN - 0022-152X
DOI - 10.1002/jhet.5570280717
Subject(s) - chemistry , dihydrofolate reductase , pyrimidine , catalysis , derivative (finance) , palladium , stereochemistry , catalytic hydrogenation , amidine , condensation , medicinal chemistry , combinatorial chemistry , organic chemistry , enzyme , financial economics , economics , physics , thermodynamics
Condensation of 2,4,6‐triaminopyrimidine ( 8 ) with bromomalonaldehyde ( 9 ) afforded, after pivaloylation, 2,4‐dipivaloyl‐6‐bromopyrido[2,3‐ d ]pyrimidine ( 11 ). This 6‐bromo derivative served as a key intermediate for the synthesis of 2,4‐diamino‐6‐[2‐(3′,4′‐dimethoxyphenyl)ethenyl]pyrido[2,3‐ d ]pyrimidine ( 5 ) via a palladium catalyzed carbon‐carbon coupling with 3,4‐dimethoxystyrene ( 12 ). Compound 5 , its 9,10‐dihydro analogue 6 and the 5,6,7,8,9,10‐hexahydro analogue 7 were of interest as potential inhibitors of dihydrofolate reductase. Compounds 6 and 7 were synthesized from 5 by catalytic hydrogenation over 5% Pd‐C.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom